Viridian Therapeutics, Inc./DE
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $742.4M
Liabilities Breakdown FY2024
Total Liabilities: $70.8M
Asset Breakdown
Total Assets: $742.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $99.6M | 13.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.2M | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $641.6M | 86.4% |
Liabilities Breakdown
Total Liabilities: $70.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 3.0% |
| Long-Term Debt | $20.6M | 29.1% |
| Other Liabilities | $48.0M | 67.9% |